Betaville

AstraZeneca said to have approached Gilead about $200 billion merger, according to Bloomberg - Part 2

So...there was no statement from AstraZeneca this morning regarding Gilead.

And both the The Times and The Daily Telegraph appear to be poring cold water on the prospect of $200 billion plus merger, which was unveiled yesterday by Bloomberg. Below is the link to The Times report:..

Read more...

AstraZeneca said to have approached Gilead about $200 billion merger, according to Bloomberg

There is a big story breaking on Bloomberg right now about AstraZeneca trying to buy Gilead to create a $200 billion pharmaceutical giant. Below is the link:..

Read more...

The cat is out of the bag at Circassia Pharmaceuticals... - Part 2

So, the cat is finally out of the bag at Circassia Pharmaceuticals: the company announced this morning that it would cancel the agreement with AstraZeneca for the US commercial rights to Tudorza and Duaklir in return for the FTSE 100 giant writing off a $150 million loan...

Read more...